Zurich Cantonal Bank
AMPH icon

Zurich Cantonal Bank’s Amphastar Pharmaceuticals AMPH Stock Holding History

Zurich Cantonal Bank’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-7,504
Closed -$201K – 2598
2025
Q4 		$201K Buy
+7,504
New +$193K ﹤0.01% 2222

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Zurich Cantonal Bank's AMPH Position: Q2 2026 in Review

Zurich Cantonal Bank held its Amphastar Pharmaceuticals (AMPH) position steady in Q2 2026 at 7,783 shares worth $157K. The position accounts for ﹤0.01% of the portfolio, ranked #2353.

Zurich Cantonal Bank first reported a position in AMPH in Q3 2015 and has held it in 43 quarters since. The position peaked at $667K in Q4 2023. 211 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

  • Zurich Cantonal Bank held 7,783 shares of Amphastar Pharmaceuticals worth $157K as of Q2 2026.
  • Zurich Cantonal Bank left its Amphastar Pharmaceuticals share count unchanged in Q2 2026.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #2353 holding.
  • Zurich Cantonal Bank first reported a position in Amphastar Pharmaceuticals in Q3 2015 and has held it in 43 quarters since.
  • Zurich Cantonal Bank's Amphastar Pharmaceuticals position peaked at $667K in Q4 2023.
  • 211 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.